Survival outcomes of patients with germ cell tumors treated with high-dose chemotherapy for refractory or relapsing disease

INTRODUCTION: Male patients with metastatic germ cell tumors can be cured in up to 96% of cases depending on stage and IGCCCG prognosis group. Treatment in relapse consists of conventional or high-dose chemotherapy (HDCT) with autologous stem cell transplantation (ASCT) combined with local treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Zschäbitz, Stefanie, Distler, Florian A, Krieger, Benjamin, Wuchter, Patrick, Schäfer-Eckart, Kerstin, Jenzer, Maximilian, Hohenfellner, Markus, Dreger, Peter, Haag, Georg Martin, Jäger, Dirk, Pahernik, Sascha, Grüllich, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976483/
https://www.ncbi.nlm.nih.gov/pubmed/29854297
http://dx.doi.org/10.18632/oncotarget.25162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976483/
https://www.ncbi.nlm.nih.gov/pubmed/29854297
http://dx.doi.org/10.18632/oncotarget.25162

Ejemplares similares